Report Categories
View AllRecent Articles
View All
CRBU Caribou Biosciences Inc posts narrower Q4 2025 loss than consensus forecasts shares rise 233 percent amid upbeat investor sentiment
SPEC Special reports quarterly results as management emphasizes strategic realignment preferred shareholders await distribution details
Fractyl Health GUTS Stock Why Restructuring Benefit Falls 20260416